These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 23296948)

  • 1. Use of mesenchymal stem cells (MSC) in chronic inflammatory fistulizing and fibrotic diseases: a comprehensive review.
    Voswinkel J; Francois S; Simon JM; Benderitter M; Gorin NC; Mohty M; Fouillard L; Chapel A
    Clin Rev Allergy Immunol; 2013 Oct; 45(2):180-92. PubMed ID: 23296948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastro-intestinal autoimmunity: preclinical experiences and successful therapy of fistulizing bowel diseases and gut Graft versus host disease by mesenchymal stromal cells.
    Voswinkel J; Francois S; Gorin NC; Chapel A
    Immunol Res; 2013 Jul; 56(2-3):241-8. PubMed ID: 23564182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human mesenchymal stem cell therapy in the management of luminal and perianal fistulizing Crohn's disease - review of pathomechanism and existing clinical data.
    Bor R; Fábián A; Farkas K; Molnár T; Szepes Z
    Expert Opin Biol Ther; 2018 Jul; 18(7):737-745. PubMed ID: 29939815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease.
    Ciccocioppo R; Bernardo ME; Sgarella A; Maccario R; Avanzini MA; Ubezio C; Minelli A; Alvisi C; Vanoli A; Calliada F; Dionigi P; Perotti C; Locatelli F; Corazza GR
    Gut; 2011 Jun; 60(6):788-98. PubMed ID: 21257987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cell effects on T-cell effector pathways.
    Duffy MM; Ritter T; Ceredig R; Griffin MD
    Stem Cell Res Ther; 2011 Aug; 2(4):34. PubMed ID: 21861858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study.
    Duijvestein M; Vos AC; Roelofs H; Wildenberg ME; Wendrich BB; Verspaget HW; Kooy-Winkelaar EM; Koning F; Zwaginga JJ; Fidder HH; Verhaar AP; Fibbe WE; van den Brink GR; Hommes DW
    Gut; 2010 Dec; 59(12):1662-9. PubMed ID: 20921206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials.
    Wang LT; Ting CH; Yen ML; Liu KJ; Sytwu HK; Wu KK; Yen BL
    J Biomed Sci; 2016 Nov; 23(1):76. PubMed ID: 27809910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refractory Complex Crohn's Perianal Fistulas: A Role for Autologous Microfragmented Adipose Tissue Injection.
    Laureti S; Gionchetti P; Cappelli A; Vittori L; Contedini F; Rizzello F; Golfieri R; Campieri M; Poggioli G
    Inflamm Bowel Dis; 2020 Jan; 26(2):321-330. PubMed ID: 31220252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRANSPLANTATION OF ADIPOSE-DERIVED MESENCHYMAL STEM CELLS IN REFRACTORY CROHN'S DISEASE: SYSTEMATIC REVIEW.
    Bernardi L; Santos CHMD; Pinheiro VAZ; Oliveira RJ; Antoniolli-Silva ACMB
    Arq Bras Cir Dig; 2019; 32(4):e1465. PubMed ID: 31859918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standardization of mesenchymal stromal cell therapy for perianal fistulizing Crohn's disease.
    Molendijk I; van der Meulen-de Jong AE; Verspaget HW; Veenendaal RA; Hommes DW; Bonsing BA; Peeters KCMJ
    Eur J Gastroenterol Hepatol; 2018 Oct; 30(10):1148-1154. PubMed ID: 30095479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single administration of human adipose tissue-derived mesenchymal stromal cells (MSC) induces durable and sustained long-term regulation of inflammatory response in experimental colitis.
    Alves VBF; de Sousa BC; Fonseca MTC; Ogata H; Caliári-Oliveira C; Yaochite JNU; Rodrigues Júnior V; Chica JEL; da Silva JS; Malmegrim KCR; Pernomian L; Cardoso CR
    Clin Exp Immunol; 2019 May; 196(2):139-154. PubMed ID: 30663040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cx601 (darvadstrocel) for the treatment of perianal fistulizing Crohn's disease.
    Bislenghi G; Wolthuis A; Van Assche G; Vermeire S; Ferrante M; D'Hoore A
    Expert Opin Biol Ther; 2019 Jul; 19(7):607-616. PubMed ID: 31121104
    [No Abstract]   [Full Text] [Related]  

  • 13. Human adipose mesenchymal stem cells as potent anti-fibrosis therapy for systemic sclerosis.
    Maria AT; Toupet K; Maumus M; Fonteneau G; Le Quellec A; Jorgensen C; Guilpain P; Noël D
    J Autoimmun; 2016 Jun; 70():31-9. PubMed ID: 27052182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stromal cell therapy for Crohn's disease.
    Liew A; O'Brien T; Egan L
    Dig Dis; 2014; 32 Suppl 1():50-60. PubMed ID: 25531353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic expanded adipose-derived mesenchymal stem cell therapy for perianal fistulas in Crohn's disease: A case series.
    Cabalzar-Wondberg D; Turina M; Biedermann L; Rogler G; Schreiner P
    Colorectal Dis; 2021 Jun; 23(6):1444-1450. PubMed ID: 33595166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mesenchymal stem cells and immunomodulation: toward new immunosuppressive strategies for the treatment of autoimmune diseases?].
    Larghero J; Vija L; Lecourt S; Michel L; Verrecchia F; Farge D
    Rev Med Interne; 2009 Mar; 30(3):287-99. PubMed ID: 18930338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem-cell therapy for perianal fistulas in Crohn's disease: a systematic review and meta-analysis.
    Cheng F; Huang Z; Li Z
    Tech Coloproctol; 2019 Jul; 23(7):613-623. PubMed ID: 31286287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix-Delivered Autologous Mesenchymal Stem Cell Therapy for Refractory Rectovaginal Crohn's Fistulas.
    Lightner AL; Dozois EJ; Dietz AB; Fletcher JG; Friton J; Butler G; Faubion WA
    Inflamm Bowel Dis; 2020 Apr; 26(5):670-677. PubMed ID: 31605115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mesenchymal stem cells and rheumatism. State of the art].
    Voswinkel J; Chapel A
    Z Rheumatol; 2012 Sep; 71(7):619-23. PubMed ID: 22825552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Potential of Umbilical Cord MSC in Crohn's Disease Is Related to Regulation of the Relative Content and Function of Th17 Lymphocytes.
    Liu J; Xu W; Xu H; Zhang S; Jin J
    Bull Exp Biol Med; 2022 Mar; 172(5):658-663. PubMed ID: 35352260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.